Depression News

A potential next-generation lithium treatment is set to be tested in major depressive disorder after the FDA issued a “study may proceed” letter for a phase 2a trial of AL001 by Alzamend Neuro.

According to presented results, a preoperative depression screening within 3 months of lumbar fusion was associated with decreased medical complications, ED utilizations and health care costs.

People with HIV have an increased risk for developing composite mental health disorders such as anxiety and depression, although receiving ART may lower this risk, researchers found.

Eating disorder claims in the United States rose 65% as a percentage of all medical claims over the last 5 years, according to a report from FAIR Health, a health care claims repository.

The COVID-19 pandemic became a stressful, disruptive experience for people of all ages and health statuses around the world.

Sleep disorders including insomnia, poor sleep quality and short and long sleep duration were associated with physical frailty among middle-aged and older patients with HIV, researchers found.

Long-term treatment with psychedelics holds the potential to transform the health care industry through millions in savings, according to an expert at a congressional briefing hosted by Johns Hopkins University.

Yoga therapy significantly reduced the felt stigma of epilepsy along with improving anxiety and quality of life at 6 months compared to sham, according to research presented in Neurology.

Neural markers can reliably distinguish mania/hypomania-specific risk from depression-specific risk in young adults, according to a study published in JAMA Psychiatry.

According to new data released by HHS, 48.7 million Americans aged 12 years or older reported a substance use disorder in the past year, including 29.5 million with an alcohol use disorder and 27.2 million with a drug use disorder.